Using a placebo-controlled crossover design , 16 individuals received four treatments in separate sessions : ( i ) anodal tDCS/PES ; ( ii ) anodal tDCS/sham PES ; ( iii ) sham tDCS/PES ; or ( iv ) sham tDCS/sham PES .